GeVIR Banner

Export Results to CSV Clear Search

Genes Fold Enrichment Color Codes
  • Gene Name, Canonical Transcript - gene identifiers from gnomAD database (Build 37)
  • GeVIR % - gene rank measured in percentiles based on Gene Variation Intolerance Ranking (GeVIR) (low values indicate more variation intolerant genes, which is also true for "LOEUF %" and "VIRLoF %"). GeVIR is a method which we developed and applied on a list of 19,361 genes to sort them based on number, length and evolutionary conservation of regions without functional variants (i.e. between two missense, loss-of-function, insertion or delition variants) in gnomAD database (version 2.0.1). Only canonical transcripts were analysed.
  • LOEUF % - gene rank measured in percentiles based gnomAD loss-of-function observed/expected upper bound fraction (LOEUF) (see Figure 1). For more information about this metric, please read "Constraint" section of MacArthur Lab blog post. If you use this metric please cite gnomAD flagship paper and use most up-to-date values from gnomAD website.

    LoF observed/expected (o/e) upper Confidence Interval (CI)

    Figure 1. Screenshot of ELN gene constraint metrics from gnomAD browser

  • VIRLoF % - gene rank measured in percentiles based on both GeVIR and gnomAD LOEUF (shows the best overall performance, see Figure 2). If you use this metric please cite both GeVIR and gnomAD flagship paper.
  • GeVIR AD, LOEUF AD, VIRLoF AD, GeVIR AR, LOEUF AR, VIRLoF AR - to help users interpret gene ranks, we calculated fold enrichment of Autosomal Dominant (AD) and Autosomal Recessive (AR) genes with known molecular basis of disorder in OMIM in a range of +-5% of gene X (see Figure 2). Statistical significant fold enrichements (Fisher Exact Test p-value < 1e-5) are shown in bold in the table. For example CDK19 gene's GeVIR % is 2.37, so examined range is from 0 (2.37-5, rounded to minimal percentile) to 7.37% (2.37+5). Genes in this range are ~4 times more often (4.05 fold enrichement) associated with AD diseases and ~4 times less often (0.25 fold enrichement) associated with AR diseases. Both enrichment of AD genes and deficiency of AR genes is statistical significant. Thus GeVIR metric adds supportive evidence that CDK19 is more likely to be associated with AD than AR disease.

    Gene Percentiles AD AR Fold Enrichment

    Figure 2. Fold Enrichment of known Autosomal Dominant (AD) and Autosomal Recessive (AR) genes of each gene in the ranked lists (GeVIR, LOEUF, VIRLoF. AD genes are enriched among top ranked genes (lowest percentiles), whereas AR genes are enriched among middle ranked genes (approximetly 35-65 percentiles). Combined metric (VIRLoF, purple) shows the best perfornance, i.e. high ranked genes are more often associated with AD than AR diseases, low ranked genes are less often associated with both AD and AR diseases.
Gene Name Canonical Transcript GeVIR % LOEUF % VIRLoF % GeVIR AD LOEUF AD VIRLoF AD GeVIR AR LOEUF AR VIRLoF AR
C22orf34 ENST00000400023 98.32 85.90 94.87 0.09 0.28 0.09 0.10 0.43 0.11
CRISP3 ENST00000433368 98.32 62.35 83.74 0.09 0.53 0.34 0.10 1.33 0.41
NKG2-E ENST00000539033 98.31 86.87 95.30 0.09 0.22 0.08 0.10 0.41 0.10
C8orf86 ENST00000358138 98.31 86.94 95.37 0.09 0.22 0.08 0.10 0.40 0.10
FCER1A ENST00000368115 98.30 75.29 89.89 0.09 0.49 0.18 0.10 0.90 0.23
ZNF320 ENST00000595635 98.30 79.48 91.73 0.09 0.38 0.14 0.10 0.66 0.18
APOBEC3G ENST00000407997 98.29 85.89 94.80 0.09 0.28 0.09 0.10 0.43 0.11
RP11-404P21.8 ENST00000553811 98.29 93.96 98.40 0.09 0.25 0.10 0.10 0.26 0.05
SPRR3 ENST00000331860 98.28 98.33 99.56 0.09 0.21 0.12 0.10 0.14 0.05
NBPF3 ENST00000318249 98.27 63.49 84.15 0.09 0.49 0.34 0.10 1.25 0.42
TAS2R31 ENST00000390675 98.27 98.54 99.87 0.09 0.20 0.12 0.10 0.15 0.04
OR7G1 ENST00000541538 98.26 99.88 99.87 0.09 0.17 0.12 0.10 0.11 0.04
GTSE1 ENST00000454366 98.26 37.35 70.03 0.09 0.76 0.47 0.10 1.65 0.91
FAM90A1 ENST00000538603 98.25 94.17 98.46 0.09 0.25 0.10 0.10 0.25 0.05
SPACA7 ENST00000283550 98.25 71.28 87.88 0.09 0.53 0.24 0.11 1.07 0.32
HRNR ENST00000368801 98.24 96.50 99.17 0.09 0.22 0.11 0.11 0.19 0.04
MNDA ENST00000368141 98.24 91.02 97.30 0.09 0.25 0.08 0.11 0.35 0.07
TCEB3CL2 ENST00000591973 98.23 98.83 99.73 0.09 0.16 0.12 0.11 0.14 0.04
PRB4 ENST00000279575 98.23 97.43 99.39 0.09 0.22 0.11 0.11 0.19 0.04
C19orf57 ENST00000346736 98.22 41.71 72.66 0.11 0.61 0.43 0.11 1.80 0.81
C10orf129 ENST00000341686 98.22 55.35 80.12 0.11 0.57 0.35 0.11 1.61 0.53
C11orf24 ENST00000304271 98.21 87.71 95.74 0.11 0.24 0.07 0.11 0.37 0.11
CXorf48 ENST00000276241 98.21 43.18 73.49 0.11 0.62 0.40 0.11 1.91 0.76
KLK3 ENST00000326003 98.20 77.80 90.98 0.11 0.42 0.15 0.11 0.79 0.20
LCN9 ENST00000277526 98.20 49.87 77.21 0.11 0.66 0.35 0.11 2.02 0.59

Cookies disclaimer

I agree Our site saves small pieces of text information (cookies) on your device in order to deliver better content and for statistical purposes. You can disable the usage of cookies by changing the settings of your browser. By browsing our website without changing the browser settings you grant us permission to store that information on your device.